FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients

R.A. Tassi, A. Gambino, L. Ardighieri, E. Bignotti, P. Todeschini, C. Romani, L. Zanotti, M. Bugatti, F. Borella, D. Katsaros, G. Tognon, E. Sartori, F. Odicino, C. Romualdi, A. Ravaggi
January 2019
Type
Journal article
Publication
British Journal of Cancer, (121), 7, pp. 584-592, https://doi.org/10.1038/s41416-019-0553-z